| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $553.5M | -21.8% |
| Cost of Revenue | $316.8M | -27.3% |
| Gross Profit | $234.8M | -17.1% |
| R&D Expense | $39.5M | -49.7% |
| SG&A Expense | $142.0M | -5.5% |
| Operating Income | $51.8M | +1.4% |
| Pre-tax Income | $34.7M | -22.9% |
| Income Tax | $11.3M | +141.2% |
| Net Income | -$237.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $130.1M | +49.0% |
| Accounts Receivable | $105.0M | -22.4% |
| Inventory | $118.0M | -39.9% |
| Current Assets | $361.4M | -15.7% |
| Total Assets | $1.12B | -23.6% |
| Current Liabilities | $197.6M | +20.0% |
| Long-term Debt | $202.5M | -25.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $13.6M | -19.5% |
| Investing Cash Flow | $45.2M | +131.9% |
| Financing Cash Flow | -$132.0M | -326.8% |
| -428.5% |
| EPS (Basic) | -$2.67 | -433.7% |
| EPS (Diluted) | -$2.64 | -434.2% |
| Stockholders' Equity |
| $756.0M |
| -26.9% |